Jörg Köhl

German Center for Lung Research — Germany

Immunology and Microbiology · Life Sciences

69h-index15.4kcitations328works3.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Complement system in diseases(147), Monoclonal and Polyclonal Antibodies Research(51), Asthma and respiratory diseases(45), Coagulation, Bradykinin, Polyphosphates, and Angioedema(44), Receptor Mechanisms and Signaling(30)

Publications328 total

Maternal antibiotic exposure-mediated alterations in basal, and allergen-induced lung function are associated with altered recruitment of eosinophils to the developing lung
Frontiers in Immunology·2025Open Access
C5aR2 fuels autoimmune skin disease in murine epidermolysis bullosa acquisita
Immunobiology·2025· 1 citedOpen Access
Charting the path of dendritic cell subsets in allergic asthma using C5aR1 fate mapping mice
Immunobiology·2025· 1 citedOpen Access
Therapeutic targeting of alternative pathway and C5 but not C5a protects from disease development in a preclinical model of autoimmune blistering dermatosis
Frontiers in Immunology·2025Open Access
Meeting Report on “10th Anniversary Symposium on Inflammatory Skin Disease”
JID Innovations·2024Open Access
Role of the Anaphylatoxin Receptor C5aR2 in Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage
American Journal of Hypertension·2024· 5 cited
C5aR-antagonism alone or in combination with MEK inhibition durably alters the plexiform neurofibroma tumor micro-environment
Journal of Pharmacology and Experimental Therapeutics·2024
DEFICIENCY OF THE COMPLEMENT RECEPTOR C5AR2 HAS NO EFFECT ON BLOOD PRESSURE AND END ORGAN DAMAGE IN ANGIOTENSIN II INDUCED HYPERTENSION
Journal of Hypertension·2024
C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis
Life Science Alliance·2024· 5 citedOpen Access
Complement activation and cellular inflammation in Fabry disease patients despite enzyme replacement therapy
Frontiers in Immunology·2024· 22 citedOpen Access
Bullous pemphigoid induced by <scp>IgG</scp> targeting type <scp>XVII</scp> collagen <scp>non‐NC16A</scp> / <scp>NC15A</scp> extracellular domains is driven by Fc gamma receptor‐ and complement‐mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade
The Journal of Pathology·2023· 19 citedOpen Access
Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II–Induced Hypertension and Hypertensive End-Organ Damage
Hypertension·2023· 6 cited
70 C5a receptor 1 controls antigen and TLR-driven T cell proliferation and differentiation by splenic conventional type 2 dendritic cells
Immunobiology·2023
183 Exploring the role of C5aR2 in neutrophil-driven autoimmune diseases: An often overlooked player in the pathogenesis of epidermolysis bullosa acquisita
Immunobiology·2023
20 The C5aR2 pathway as a potential novel checkpoint for B cell activation and differentiation
Immunobiology·2023
33 C5 cleavage inhibition combined with C3 convertase targeting protects from disease development in a preclinical model of autoimmune skin disease
Immunobiology·2023
214 Platelets balance revascularization by anaphylatoxin C5a receptor-dependent release of paracrine factors
Immunobiology·2023
24 The C5a/C5aR1 axis controls the induction of Germinal Center B cells, their IgM/IgG1 production and plasma cell differentiation
Immunobiology·2023
The Platelet Anaphylatoxin Receptor C5aR1 (CD88) Is a Promising Target for Modulating Vessel Growth in Response to Ischemiaa
TH Open·2023· 2 citedOpen Access
Complement‐mediated immune mechanisms in allergy
European Journal of Immunology·2023· 15 citedOpen Access
page 1 of 17Next →

Frequent Co-authors

Andreas Klos(9), Manoj K. Pandey(7), Wilfried Bautsch(7), Christian M. Karsten(6), Craig Gérard(5), Marc Ehlers(4), J. Engelbert Gessner(4), Claudia Kemper(3), Markus Berger(3), Dominique Petzold(3), Véronique Blanchard(3), André Winkler(3), Constanze Heß(3), Richard T. Strait(3), Fred D. Finkelman(3), Marsha Wills‐Karp(3), Heiko Hawlisch(3), Nico van Rooijen(3), Yves Laumonnier(3), Edimara S. Reis(2)